About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference 02-27-2023 at 4:05 PM EST Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results 02-14-2023 at 4:05 PM EST Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023 01-23-2023 at 4:05 PM EST VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations 43rd Annual Cowen Healthcare Conference Mar 6, 2023 at 12:50 PM EST Listen to webcast Adaptive Biotechnologies Fourth Quarter Financial Results Feb 14, 2023 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q4 2022 Earnings Presentation 1.9 MB 41st Annual J.P. Morgan Healthcare Conference Jan 9, 2023 at 1:30 PM PST Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Mar 30, 2023 5:11 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
